News Chart Alimera Sciences, Inc.

Equities

ALIM

US0162592028

Real-time Estimate Cboe BZX Other stock markets 12:51:38 2024-05-13 pm EDT			5-day change	1st Jan Change
3.545 ^USD	-0.28%		-5.60%	-18.06%

Mar. 25	Maxim Initiates Alimera Sciences at Buy Rating With $10 Price Target	MT
Mar. 19	Alimera Sciences, Inc. Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina Network	CI

303d4e220739f3793.cJ83SbKytcMJMU9OwAhs4msbNmLaxvAYEQRwZudGbMg.HdcDPvSFhYZZdTYUhEMchjxBRyrpopQoQ35dMKYqBp8h1QA7x-v7qzp5Fg~f082c2eabc57d11cf52ceb0ab1d878b3